NLS Pharmaceutics
NLSP
NLSP
4 hedge funds and large institutions have $72K invested in NLS Pharmaceutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$36K |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$11K |
| 3 |
3
Renaissance Technologies
New York
|
$16K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| 2 |
AC
2
Armistice Capital
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $36K | +$36K | +1,437 | New |
|
|
2
Renaissance Technologies
New York
| $16K | +$3.6K | +145 | +29% |
|
|
TSS
3
Two Sigma Securities
New York
| $11K | +$11K | +441 | New |
|
4
Geode Capital Management
Boston,
Massachusetts
| $9K | – | – | – |
|
|
AC
5
Armistice Capital
New York
| – | -$714 | -30,410 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$9K | -381 | Closed |
|